Sponsors
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Blog
Chairman, GDS International
Sales and the 'Talent Magnet'
A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?25 May 2011
White Papers
Focus Area: Manufacturing
Aspetic spray drying installation
The aseptic spray drying installation acquired by Hovione is the only one known to us that has successfully passed a FDA PAI (Pre-Approval Inspection).
Building kinase switches
Design and development of small molecule kinase inhibitors is a challenging task. A chemical genetics approach modulating kinase function is finding its way into pharma drug discovery programs via the use of innovative new mouse models.
The key to cost-effective manufacturing
Moving products to market quickly remains a challenge for any company, in particular those developing biotherapeutics and vaccines. As new biologics are developed for more specialized applications, the demand for large manufacturing plants with tens of thousands of liters in bioreactor capacity is diminishing.
Biomarker discovery via monoclonal antibody microarrays
A Biochip Protein Profiling Array, utilising monoclonal antibody (mAB) libraries generated against the natural human plasma proteome.
Purpose-built informatics solutions improve enterprise level productivity for pharmaceutical companies and their strategic partners
As raw material costs continue to rise and more stringent R&D and regulatory requirements are mandated, pharmaceutical companies continue to experience lengthy time to market schedules and the pressure to contain costs is at an all time high.
Source: www.ngpharma.com© 2012 GDS Publishing Ltd. All rights reserved.